News & Updates

Adult men with prostate cancer who have increasing exposure to androgen deprivation therapy (ADT) are at greater risk of dementia, according to a US study.

A supervised high-intensity interval training (HIIT) program for 12 weeks leads to improvements in prostate cancer-specific anxiety, fear of cancer progression, hormone symptoms, stress, fatigue, and self-esteem in men on active surveillance, reports a study.

While survival among multiple myeloma patients has been improving over time, the development of secondary primary malignancies seems to offset this effect by increasing the risk of mortality, a recent study has found.

In patients with multiple myeloma (MM), the chromosome translocation t(11;14) does not seem to be associated with worse prognosis, resulting in similar treatment outcomes as other standard-risk subgroups, reports a recent study.

Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.